BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31964323)

  • 1. FDG-PET/CT Assessment of Pulmonary Sarcoidosis: A Guide for Internists.
    Tana M; di Carlo S; Romano M; Alessandri M; Schiavone C; Montagnani A
    Curr Med Imaging Rev; 2019; 15(1):21-25. PubMed ID: 31964323
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
    Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.
    Papiris SA; Manali ED; Pianou NK; Kallergi M; Papaioannou AI; Georgakopoulos A; Malagari K; Kelekis NL; Gialafos H; Chatziioannou S
    Expert Rev Respir Med; 2020 Jan; 14(1):103-110. PubMed ID: 31626563
    [No Abstract]   [Full Text] [Related]  

  • 4. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.
    Akaike G; Itani M; Shah H; Ahuja J; Yilmaz Gunes B; Assaker R; Behnia F
    Radiographics; 2018; 38(5):1536-1549. PubMed ID: 30118393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utility of Whole Body
    Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
    Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of
    Rubini G; Ferrari C; Altini C; Cimino A; Fanelli M; Niccoli Asabella A
    Curr Med Imaging Rev; 2019; 15(1):32-38. PubMed ID: 31964325
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
    Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
    Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of
    Chen H; Jin R; Wang Y; Li L; Li K; He Y
    Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of pulmonary sarcoidosis.
    Israel-Biet D; Valeyre D
    Curr Opin Pulm Med; 2013 Sep; 19(5):510-5. PubMed ID: 23880701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications.
    Maccarone MT
    Curr Med Imaging Rev; 2019; 15(1):4-9. PubMed ID: 31964321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series.
    Ordóñez-Rubiano EG; Solano-Noguera DF; Row W; Weinberg J; Tatsui CE; Johnson JM; Gule-Monroe MK
    Spine (Phila Pa 1976); 2019 Nov; 44(21):E1248-E1255. PubMed ID: 31634300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of whole-body
    Saleh JK; Barkmeier D; Frey KA; Davenport MS
    J Nucl Cardiol; 2023 Oct; 30(5):1773-1781. PubMed ID: 36829085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.
    Mostard RL; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Vöö S; Drent M
    Respir Med; 2013 Mar; 107(3):439-47. PubMed ID: 23261309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous use of FDG-18 and
    Tetikkurt C; Sayman H; Dedeoglu SE; Kubat B; Tetikkurt S
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32724228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An atypical sarcoidosis involvement in FDG PET/CT: A case report.
    Robin P; Benigni P; Feger B; Salaun PY; Abgral R
    Medicine (Baltimore); 2016 Dec; 95(52):e5700. PubMed ID: 28033265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
    Keijsers RG; Grutters JC; Thomeer M; Du Bois RM; Van Buul MM; Lavalaye J; Van Den Bosch JM; Verzijlbergen FJ
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):66-71. PubMed ID: 21242947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serial F-18 FDG PET/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis.
    Maturu VN; Rayamajhi SJ; Agarwal R; Aggarwal AN; Gupta D; Mittal BR
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):372-380. PubMed ID: 28079849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients.
    Tetikkurt C; Yanardag H; Sayman BH; Bilir M; Tetikkurt S; Bilgic S; Kubat B; Bilgin S
    Monaldi Arch Chest Dis; 2020 Dec; 90(4):. PubMed ID: 33372740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.